Incentive salience: novel treatment strategies for major depression

This article proposes that a recent shift in our understanding of dopamine function may support translational research to target deficits in positive emotions and reward processing in individuals with major depressive disorder (MDD). We review how dopamine functions to modulate approach behaviors in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:CNS spectrums 2013-12, Vol.18 (6), p.307-314
Hauptverfasser: Soskin, David P., Holt, Daphne J., Sacco, Garret R., Fava, Maurizio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 314
container_issue 6
container_start_page 307
container_title CNS spectrums
container_volume 18
creator Soskin, David P.
Holt, Daphne J.
Sacco, Garret R.
Fava, Maurizio
description This article proposes that a recent shift in our understanding of dopamine function may support translational research to target deficits in positive emotions and reward processing in individuals with major depressive disorder (MDD). We review how dopamine functions to modulate approach behaviors in response to positive incentives, and we describe the incentive salience hypothesis, which posits that dopamine primarily modulates “wanting,” or anticipatory reward, rather than “liking,” or subjective pleasure. Although the incentive salience hypothesis was first proposed to help explain how drugs of abuse may reinforce harmful behaviors in the absence of continued pleasure or “liking,” it may also provide a basis for understanding and developing new treatment approaches for MDD. Specifically, it provides a rationale for combining behaviorally activating psychotherapies and pro-dopaminergic agents to target impaired reward processing in MDD.
doi_str_mv 10.1017/S1092852913000345
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1465176067</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_S1092852913000345</cupid><sourcerecordid>2844766580</sourcerecordid><originalsourceid>FETCH-LOGICAL-c373t-97a0431134673dddc281d21215f25bafe8d1ebd952416501ed6715ece24d1c693</originalsourceid><addsrcrecordid>eNp1kE1Lw0AQhhdRbK3-AC8S8OIlurOfiTcpfhQKHtRz2GQnJSUfdTcp-O_d0KqgeNlhed95ZuYl5BzoNVDQNy9AU5ZIlgKnlHIhD8iUgZKxkjQ9JNNRjkd9Qk68X1MquE74MZkwnlJOmZ6S-aItsO2rLUbe1BWG323Udluso96h6ZsgRr53psdVhT4qOxc1Zh1eixuH3ldde0qOSlN7PNvXGXl7uH-dP8XL58fF_G4ZF1zzPk61CQsAcKE0t9YWLAHLgIEsmcxNiYkFzG0qmQg3UECrNEgskAkLhUr5jFztuBvXvQ_o-6ypfIF1bVrsBp-BUBK0ogE_I5e_rOtucG3YLmOJEFopmdDggp2rcJ33Dsts46rGuI8MaDYmnP1JOPRc7MlD3qD97viKNBj4Hmqa3FV2hT-z_8d-AvAZg9M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2844766580</pqid></control><display><type>article</type><title>Incentive salience: novel treatment strategies for major depression</title><source>MEDLINE</source><source>Cambridge University Press Journals Complete</source><creator>Soskin, David P. ; Holt, Daphne J. ; Sacco, Garret R. ; Fava, Maurizio</creator><creatorcontrib>Soskin, David P. ; Holt, Daphne J. ; Sacco, Garret R. ; Fava, Maurizio</creatorcontrib><description>This article proposes that a recent shift in our understanding of dopamine function may support translational research to target deficits in positive emotions and reward processing in individuals with major depressive disorder (MDD). We review how dopamine functions to modulate approach behaviors in response to positive incentives, and we describe the incentive salience hypothesis, which posits that dopamine primarily modulates “wanting,” or anticipatory reward, rather than “liking,” or subjective pleasure. Although the incentive salience hypothesis was first proposed to help explain how drugs of abuse may reinforce harmful behaviors in the absence of continued pleasure or “liking,” it may also provide a basis for understanding and developing new treatment approaches for MDD. Specifically, it provides a rationale for combining behaviorally activating psychotherapies and pro-dopaminergic agents to target impaired reward processing in MDD.</description><identifier>ISSN: 1092-8529</identifier><identifier>EISSN: 2165-6509</identifier><identifier>DOI: 10.1017/S1092852913000345</identifier><identifier>PMID: 23903027</identifier><language>eng</language><publisher>New York, USA: Cambridge University Press</publisher><subject>Amphetamines ; Animals ; Antidepressants ; Antidepressive Agents - therapeutic use ; Cognitive Therapy ; Depressive Disorder, Major - metabolism ; Depressive Disorder, Major - psychology ; Depressive Disorder, Major - therapy ; Dopamine ; Dopamine - metabolism ; Humans ; Hypotheses ; Kinases ; Mental depression ; Motivation ; Psychotropic drugs ; Review Articles ; Sucrose ; Tuberculosis</subject><ispartof>CNS spectrums, 2013-12, Vol.18 (6), p.307-314</ispartof><rights>Copyright © Cambridge University Press 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c373t-97a0431134673dddc281d21215f25bafe8d1ebd952416501ed6715ece24d1c693</citedby><cites>FETCH-LOGICAL-c373t-97a0431134673dddc281d21215f25bafe8d1ebd952416501ed6715ece24d1c693</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.cambridge.org/core/product/identifier/S1092852913000345/type/journal_article$$EHTML$$P50$$Gcambridge$$H</linktohtml><link.rule.ids>164,314,780,784,27924,27925,55628</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23903027$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Soskin, David P.</creatorcontrib><creatorcontrib>Holt, Daphne J.</creatorcontrib><creatorcontrib>Sacco, Garret R.</creatorcontrib><creatorcontrib>Fava, Maurizio</creatorcontrib><title>Incentive salience: novel treatment strategies for major depression</title><title>CNS spectrums</title><addtitle>CNS Spectr</addtitle><description>This article proposes that a recent shift in our understanding of dopamine function may support translational research to target deficits in positive emotions and reward processing in individuals with major depressive disorder (MDD). We review how dopamine functions to modulate approach behaviors in response to positive incentives, and we describe the incentive salience hypothesis, which posits that dopamine primarily modulates “wanting,” or anticipatory reward, rather than “liking,” or subjective pleasure. Although the incentive salience hypothesis was first proposed to help explain how drugs of abuse may reinforce harmful behaviors in the absence of continued pleasure or “liking,” it may also provide a basis for understanding and developing new treatment approaches for MDD. Specifically, it provides a rationale for combining behaviorally activating psychotherapies and pro-dopaminergic agents to target impaired reward processing in MDD.</description><subject>Amphetamines</subject><subject>Animals</subject><subject>Antidepressants</subject><subject>Antidepressive Agents - therapeutic use</subject><subject>Cognitive Therapy</subject><subject>Depressive Disorder, Major - metabolism</subject><subject>Depressive Disorder, Major - psychology</subject><subject>Depressive Disorder, Major - therapy</subject><subject>Dopamine</subject><subject>Dopamine - metabolism</subject><subject>Humans</subject><subject>Hypotheses</subject><subject>Kinases</subject><subject>Mental depression</subject><subject>Motivation</subject><subject>Psychotropic drugs</subject><subject>Review Articles</subject><subject>Sucrose</subject><subject>Tuberculosis</subject><issn>1092-8529</issn><issn>2165-6509</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kE1Lw0AQhhdRbK3-AC8S8OIlurOfiTcpfhQKHtRz2GQnJSUfdTcp-O_d0KqgeNlhed95ZuYl5BzoNVDQNy9AU5ZIlgKnlHIhD8iUgZKxkjQ9JNNRjkd9Qk68X1MquE74MZkwnlJOmZ6S-aItsO2rLUbe1BWG323Udluso96h6ZsgRr53psdVhT4qOxc1Zh1eixuH3ldde0qOSlN7PNvXGXl7uH-dP8XL58fF_G4ZF1zzPk61CQsAcKE0t9YWLAHLgIEsmcxNiYkFzG0qmQg3UECrNEgskAkLhUr5jFztuBvXvQ_o-6ypfIF1bVrsBp-BUBK0ogE_I5e_rOtucG3YLmOJEFopmdDggp2rcJ33Dsts46rGuI8MaDYmnP1JOPRc7MlD3qD97viKNBj4Hmqa3FV2hT-z_8d-AvAZg9M</recordid><startdate>201312</startdate><enddate>201312</enddate><creator>Soskin, David P.</creator><creator>Holt, Daphne J.</creator><creator>Sacco, Garret R.</creator><creator>Fava, Maurizio</creator><general>Cambridge University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M2M</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>201312</creationdate><title>Incentive salience: novel treatment strategies for major depression</title><author>Soskin, David P. ; Holt, Daphne J. ; Sacco, Garret R. ; Fava, Maurizio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c373t-97a0431134673dddc281d21215f25bafe8d1ebd952416501ed6715ece24d1c693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Amphetamines</topic><topic>Animals</topic><topic>Antidepressants</topic><topic>Antidepressive Agents - therapeutic use</topic><topic>Cognitive Therapy</topic><topic>Depressive Disorder, Major - metabolism</topic><topic>Depressive Disorder, Major - psychology</topic><topic>Depressive Disorder, Major - therapy</topic><topic>Dopamine</topic><topic>Dopamine - metabolism</topic><topic>Humans</topic><topic>Hypotheses</topic><topic>Kinases</topic><topic>Mental depression</topic><topic>Motivation</topic><topic>Psychotropic drugs</topic><topic>Review Articles</topic><topic>Sucrose</topic><topic>Tuberculosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Soskin, David P.</creatorcontrib><creatorcontrib>Holt, Daphne J.</creatorcontrib><creatorcontrib>Sacco, Garret R.</creatorcontrib><creatorcontrib>Fava, Maurizio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Psychology Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>CNS spectrums</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Soskin, David P.</au><au>Holt, Daphne J.</au><au>Sacco, Garret R.</au><au>Fava, Maurizio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incentive salience: novel treatment strategies for major depression</atitle><jtitle>CNS spectrums</jtitle><addtitle>CNS Spectr</addtitle><date>2013-12</date><risdate>2013</risdate><volume>18</volume><issue>6</issue><spage>307</spage><epage>314</epage><pages>307-314</pages><issn>1092-8529</issn><eissn>2165-6509</eissn><abstract>This article proposes that a recent shift in our understanding of dopamine function may support translational research to target deficits in positive emotions and reward processing in individuals with major depressive disorder (MDD). We review how dopamine functions to modulate approach behaviors in response to positive incentives, and we describe the incentive salience hypothesis, which posits that dopamine primarily modulates “wanting,” or anticipatory reward, rather than “liking,” or subjective pleasure. Although the incentive salience hypothesis was first proposed to help explain how drugs of abuse may reinforce harmful behaviors in the absence of continued pleasure or “liking,” it may also provide a basis for understanding and developing new treatment approaches for MDD. Specifically, it provides a rationale for combining behaviorally activating psychotherapies and pro-dopaminergic agents to target impaired reward processing in MDD.</abstract><cop>New York, USA</cop><pub>Cambridge University Press</pub><pmid>23903027</pmid><doi>10.1017/S1092852913000345</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1092-8529
ispartof CNS spectrums, 2013-12, Vol.18 (6), p.307-314
issn 1092-8529
2165-6509
language eng
recordid cdi_proquest_miscellaneous_1465176067
source MEDLINE; Cambridge University Press Journals Complete
subjects Amphetamines
Animals
Antidepressants
Antidepressive Agents - therapeutic use
Cognitive Therapy
Depressive Disorder, Major - metabolism
Depressive Disorder, Major - psychology
Depressive Disorder, Major - therapy
Dopamine
Dopamine - metabolism
Humans
Hypotheses
Kinases
Mental depression
Motivation
Psychotropic drugs
Review Articles
Sucrose
Tuberculosis
title Incentive salience: novel treatment strategies for major depression
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T20%3A50%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incentive%20salience:%20novel%20treatment%20strategies%20for%20major%20depression&rft.jtitle=CNS%20spectrums&rft.au=Soskin,%20David%20P.&rft.date=2013-12&rft.volume=18&rft.issue=6&rft.spage=307&rft.epage=314&rft.pages=307-314&rft.issn=1092-8529&rft.eissn=2165-6509&rft_id=info:doi/10.1017/S1092852913000345&rft_dat=%3Cproquest_cross%3E2844766580%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2844766580&rft_id=info:pmid/23903027&rft_cupid=10_1017_S1092852913000345&rfr_iscdi=true